Lin Cheng, PhD

Chief Technology Officer

20+ years in medicinal chemistry and drug development; led over 30 drug development programs in cancer immunology, inflammation, pain management, HIV-AIDS, and renal diseases, with hundreds of publications and patents; inventor of marketed drug MOVANTIK®

Lin Cheng, PhD